D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
-1.38%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$76.1B
AUM Growth
-$5.9B
Cap. Flow
-$11.4B
Cap. Flow %
-15.01%
Top 10 Hldgs %
11.78%
Holding
4,789
New
766
Increased
1,441
Reduced
1,509
Closed
487

Top Buys

1
AAPL icon
Apple
AAPL
+$392M
2
SBUX icon
Starbucks
SBUX
+$370M
3
PFE icon
Pfizer
PFE
+$338M
4
PYPL icon
PayPal
PYPL
+$320M
5
SCHW icon
Charles Schwab
SCHW
+$305M

Sector Composition

1 Technology 19.01%
2 Consumer Discretionary 12.74%
3 Financials 11.39%
4 Healthcare 11.24%
5 Energy 7.23%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PFC
3026
DELISTED
Premier Financial Corp. Common Stock
PFC
$531K ﹤0.01%
17,501
+9,935
+131% +$301K
VKTX icon
3027
Viking Therapeutics
VKTX
$2.79B
$529K ﹤0.01%
+176,278
New +$529K
FAZE
3028
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$528K ﹤0.01%
53,192
-17,602
-25% -$175K
ANGO icon
3029
AngioDynamics
ANGO
$433M
$527K ﹤0.01%
24,450
-27,603
-53% -$595K
BBAR icon
3030
BBVA Argentina
BBAR
$1.84B
$526K ﹤0.01%
+148,301
New +$526K
SXI icon
3031
Standex International
SXI
$2.47B
$523K ﹤0.01%
5,237
-5,386
-51% -$538K
CRBP icon
3032
Corbus Pharmaceuticals
CRBP
$116M
$522K ﹤0.01%
32,764
+5,447
+20% +$86.8K
IRMD icon
3033
iRadimed
IRMD
$907M
$521K ﹤0.01%
+11,620
New +$521K
CND.WS
3034
DELISTED
Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CND.WS
$521K ﹤0.01%
437,500
SPNS icon
3035
Sapiens International
SPNS
$2.4B
$519K ﹤0.01%
20,425
-13,276
-39% -$337K
VRE
3036
Veris Residential
VRE
$1.49B
$519K ﹤0.01%
29,827
+18,156
+156% +$316K
DBI icon
3037
Designer Brands
DBI
$225M
$517K ﹤0.01%
38,247
-658,745
-95% -$8.9M
ACT icon
3038
Enact Holdings
ACT
$5.79B
$515K ﹤0.01%
+23,148
New +$515K
HCVIW
3039
DELISTED
Hennessy Capital Investment Corp. VI Warrant
HCVIW
$515K ﹤0.01%
990,000
PDSB icon
3040
PDS Biotechnology
PDSB
$54.5M
$514K ﹤0.01%
83,112
+53,507
+181% +$331K
HCCI
3041
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$514K ﹤0.01%
17,356
-12,799
-42% -$379K
HYT icon
3042
BlackRock Corporate High Yield Fund
HYT
$1.53B
$512K ﹤0.01%
47,500
PPL icon
3043
PPL Corp
PPL
$26.7B
$512K ﹤0.01%
17,941
-136,451
-88% -$3.89M
SEIC icon
3044
SEI Investments
SEIC
$10.7B
$512K ﹤0.01%
8,505
-70,634
-89% -$4.25M
SSP icon
3045
E.W. Scripps
SSP
$257M
$512K ﹤0.01%
24,627
-44,057
-64% -$916K
RICK icon
3046
RCI Hospitality Holdings
RICK
$304M
$511K ﹤0.01%
8,309
-5,759
-41% -$354K
BWA icon
3047
BorgWarner
BWA
$9.46B
$509K ﹤0.01%
14,871
-150,084
-91% -$5.14M
LYV icon
3048
Live Nation Entertainment
LYV
$40.3B
$509K ﹤0.01%
4,323
-1,838
-30% -$216K
WST icon
3049
West Pharmaceutical
WST
$18.2B
$503K ﹤0.01%
1,224
+571
+87% +$235K
LE icon
3050
Lands' End
LE
$475M
$502K ﹤0.01%
29,672
+3,237
+12% +$54.8K